SCHEMBL4655706

SCHEMBL4655706

CN(C)/C=C/C(=O)c1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.61
CSF1R P07333 6/20 0.59
CYP2C9 P11712 2/20 0.57
BRAF P15056 2/20 0.57
MAPK14 Q16539 2/20 0.57
JAK2 O60674 1/20 0.57
PDGFRB P09619 1/20 0.57
FGFR1 P11362 1/20 0.57
EPHB4 P54760 1/20 0.57
PTK2 Q05397 1/20 0.57
BTK Q06187 1/20 0.54
PTGS1 P23219 2/20 0.53
MEN1 O00255 1/20 0.53
HTT P42858 1/20 0.53
RAB9A P51151 1/20 0.53
KMT2A Q03164 1/20 0.53
KCNK3 O14649 2/20 0.52
MAPT P10636 1/20 0.52
KCNK9 Q9NPC2 1/20 0.52
KCNQ3 O43525 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4655710 1.00 ALDH1A1 (0.61) ALDH1A1CSF1RCYP2C9BRAFMAPK14
SCHEMBL4655771 0.85 ALDH1A1 (0.77) ALDH1A1BTKPTGS1MEN1HTT
SCHEMBL4655770 0.85 ALDH1A1 (0.77) ALDH1A1BTKPTGS1MEN1HTT
SCHEMBL2497820 0.81 CSF1R (0.70) CSF1RCYP2C9BRAFMAPK14JAK2
SCHEMBL14468045 0.78 MEN1 (0.68) CSF1RCYP2C9BRAFMAPK14PTGS1
SCHEMBL99941 0.77 ALDH1A1 (1.00) ALDH1A1HTTRAB9AMAPTLMNA
SCHEMBL99942 0.77 ALDH1A1 (1.00) ALDH1A1HTTRAB9AMAPTLMNA
SCHEMBL14286496 0.76 CSF1R (0.75) CSF1RCYP2C9BRAFMAPK14JAK2
SCHEMBL2495506 0.76 MAPT (0.61) CSF1RCYP2C9BRAFMAPK14JAK2
SCHEMBL2950273 0.76 CSF1R (0.81) CSF1RCYP2C9BRAFMAPK14JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1996594-A2 PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF Wyeth a Corporation of the State of Delaware (US) 2008-12-03 EP disclosed
WO-2007109093-A2 PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF WYETH (US) 2007-09-27 WO disclosed
US-20070219186-A1 Pyrazolo[1,5-A]pyrimidine derivatives and methods of use thereof WYETH (US) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219186-A1 Pyrazolo[1,5-A]pyrimidine derivatives and methods of use thereof DPYD, TYMP, TYMS ALDH1A1 253/4885CSF1R 3829/4885CYP2C9 355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.